Fang Liu

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Bipolar Disorder

Angiotensin Converting Enzyme

Tyrosine Kinase

Top Venues

Molecular brain

Science signaling

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Dongxu Zhai, Shuxin Yan, James Samsom, Le Wang, Ping Su, Anlong Jiang, Haorui Zhang, Zhengping Jia, Izhar Wallach, Abraham Heifets, Chiara Zanato, Chih-Chung Tseng, Albert H C Wong, Iain R Greig, Fang Liu
Small-molecule targeting AMPA-mediated excitotoxicity has therapeutic effects in mouse models for multiple sclerosis. Science advances 9 (49) (2023)
Ping Su, Dongxu Zhai, Albert H C Wong, Fang Liu
Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice. Molecular brain 15 (1) (2022)
Anlong Jiang, Ping Su, Shupeng Li, Albert H C Wong, Fang Liu
Disrupting the α7nAChR-NR2A protein complex exerts antidepressant-like effects. Molecular brain 14 (1) (2021)
Ping Su, Hailong Zhang, Albert H C Wong, Fang Liu
The DISC1 R264Q variant increases affinity for the dopamine D2 receptor and increases GSK3 activity. Molecular brain 13 (1) (2020)
Frankie H F Lee, Terence K Y Lai, Ping Su, Fang Liu
Altered cortical Cytoarchitecture in the Fmr1 knockout mouse. Molecular brain 12 (1) (2019)
Ping Su, Terence K Y Lai, Frankie H F Lee, Andrew R Abela, Paul J Fletcher, Fang Liu
Disruption of SynGAP-dopamine D1 receptor complexes alters actin and microtubule dynamics and impairs GABAergic interneuron migration. Science signaling 12 (593) (2019)